Molecular Mechanisms and Biological Functions of siRNA.

Hassan Dana, Ghanbar Mahmoodi Chalbatani, Habibollah Mahmoodzadeh, Rezvan Karimloo, Omid Rezaiean, Amirreza Moradzadeh, Narges Mehmandoost, Fateme Moazzen, Ali Mazraeh, Vahid Marmari, Mohammad Ebrahimi, Mohammad Menati Rashno, Saeid Jan Abadi, Elahe Gharagouzlo
{"title":"Molecular Mechanisms and Biological Functions of siRNA.","authors":"Hassan Dana,&nbsp;Ghanbar Mahmoodi Chalbatani,&nbsp;Habibollah Mahmoodzadeh,&nbsp;Rezvan Karimloo,&nbsp;Omid Rezaiean,&nbsp;Amirreza Moradzadeh,&nbsp;Narges Mehmandoost,&nbsp;Fateme Moazzen,&nbsp;Ali Mazraeh,&nbsp;Vahid Marmari,&nbsp;Mohammad Ebrahimi,&nbsp;Mohammad Menati Rashno,&nbsp;Saeid Jan Abadi,&nbsp;Elahe Gharagouzlo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>One of the most important advances in biology has been the discovery that siRNA (small interfering RNA) is able to regulate the expression of genes, by a phenomenon known as RNAi (RNA interference). The discovery of RNAi, first in plants and <i>Caenorhabditis elegans</i> and later in mammalian cells, led to the emergence of a transformative view in biomedical research. siRNA has gained attention as a potential therapeutic reagent due to its ability to inhibit specific genes in many genetic diseases. siRNAs can be used as tools to study single gene function both in vivo and in-vitro and are an attractive new class of therapeutics, especially against undruggable targets for the treatment of cancer and other diseases. The siRNA delivery systems are categorized as non-viral and viral delivery systems. The non-viral delivery system includes polymers; Lipids; peptides etc. are the widely studied delivery systems for siRNA. Effective pharmacological use of siRNA requires 'carriers' that can deliver the siRNA to its intended site of action. The carriers assemble the siRNA into supramolecular complexes that display functional properties during the delivery process.</p>","PeriodicalId":13852,"journal":{"name":"International Journal of Biomedical Science : IJBS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542916/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biomedical Science : IJBS","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

One of the most important advances in biology has been the discovery that siRNA (small interfering RNA) is able to regulate the expression of genes, by a phenomenon known as RNAi (RNA interference). The discovery of RNAi, first in plants and Caenorhabditis elegans and later in mammalian cells, led to the emergence of a transformative view in biomedical research. siRNA has gained attention as a potential therapeutic reagent due to its ability to inhibit specific genes in many genetic diseases. siRNAs can be used as tools to study single gene function both in vivo and in-vitro and are an attractive new class of therapeutics, especially against undruggable targets for the treatment of cancer and other diseases. The siRNA delivery systems are categorized as non-viral and viral delivery systems. The non-viral delivery system includes polymers; Lipids; peptides etc. are the widely studied delivery systems for siRNA. Effective pharmacological use of siRNA requires 'carriers' that can deliver the siRNA to its intended site of action. The carriers assemble the siRNA into supramolecular complexes that display functional properties during the delivery process.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
siRNA的分子机制和生物学功能。
生物学最重要的进展之一是发现siRNA(小干扰RNA)能够通过一种被称为RNAi (RNA干扰)的现象来调节基因的表达。RNAi的发现,首先是在植物和秀丽隐杆线虫中,后来在哺乳动物细胞中,导致了生物医学研究中一个变革性观点的出现。siRNA作为一种潜在的治疗试剂受到了关注,因为它能够抑制许多遗传疾病中的特定基因。sirna可以作为研究体内和体外单基因功能的工具,是一类有吸引力的新疗法,特别是针对癌症和其他疾病的不可药物靶点。siRNA传递系统分为非病毒传递系统和病毒传递系统。非病毒传递系统包括聚合物;脂质;多肽等是siRNA被广泛研究的传递系统。siRNA的有效药理应用需要能够将siRNA运送到其预期作用部位的“载体”。载体将siRNA组装成在递送过程中显示功能特性的超分子复合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Tongue Prints - An Information Immune to Forgery Mesenchymal Stem Cells and Their Derivatives for Skin Rejuvenation Fibrodysplasia Ossificans Progressiva: Molecular Mechanism, Drug Development and Current Clinical Trials EFNA3 is involved in Immune Regulation and the Ras Signal Pathway in Hepatocellular Carcinoma Recent Advance in Understanding Vitamin D in Postpartum Depression
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1